-
Stock Highlights: Avalanche Biotechnologies (NASDAQ:AAVL), Anthera Pharmaceuticals (NASDAQ:ANTH), Sequenom Inc. (NASDAQ:SQNM), Hillenbrand (NYSE:HI), Snap-on Incorporated (NYSE:SNA)
On Tuesday shares of Avalanche Biotechnologies, Inc. (NASDAQ:AAVL) closed at $33.88. Avalanche Biotechnologies, Inc. (NASDAQ:AAVL), announced that on May 3-7,, it and certain of its research partners presented at the Association for Research in Vision and Ophthalmology(ARVO) 2015 Annual Meeting in Denver, as well as at the American Society of Gene & Cell Therapy (ASGCT)…
-
Watch List: Avalanche Biotechnologies (NASDAQ:AAVL), Fate Therapeutics (NASDAQ:FATE), ChipMOS TECHNOLOGIES (NASDAQ:IMOS), Rackspace Hosting (NYSE:RAX), Tempur Sealy International Inc. (NYSE:TPX)
On Monday shares of Avalanche Biotechnologies, Inc. (NASDAQ:AAVL) closed at $34.85. Avalanche Biotechnologies, Inc. (NASDAQ:AAVL), announced that the company and certain of its research partners presented at the Association for Research in Vision and Ophthalmology(ARVO) 2015 Annual Meeting in Denver, as well as at the American Society of Gene & Cell Therapy (ASGCT) 18th Annual…
-
Stocks to Watch: Intrexon Corporation (NYSE:XON), Avalanche Biotechnologies (NASDAQ:AAVL), NN Inc. (NASDAQ:NNBR), Honda Motor Co., (NYSE:HMC), Microsoft Corporation (NASDAQ:MSFT)
On Friday shares of Intrexon Corporation (NYSE:XON) closed at $42.84.Intrexon Corporation (NYSE:XON) announced it will release first quarter 2015 financial results after the market closes on May 11, 2015. Avalanche Biotechnologies, Inc. (NASDAQ:AAVL) in last trading activity fell -1.73% to close at $32.47. Company weekly performance is -2.11% while its quarterly performance stands at -2.40%.…
-
Fast Moving Stocks: Avalanche Biotechnologies (NASDAQ:AAVL), Vitae Pharmaceuticals (NASDAQ:VTAE), Leggett & Platt, Incorporated (NYSE:LEG), Expedia Inc. (NASDAQ:EXPE), SB Financial (NASDAQ:SBFG)
On Thursday shares of Avalanche Biotechnologies, Inc. (NASDAQ:AAVL) closed at $31.86. Avalanche Biotechnologies, Inc. (NASDAQ:AAVL), announced that in May, it and certain of its research partners will present at Elizabeth (Piroska) Rakoczy, PhD, The University of Western Australia, on Monday, May 4, 8:45 a.m. – 9:00 a.m. MT. Vitae Pharmaceuticals, Inc. (NASDAQ:VTAE) in last trading…
-
Morning Watch List: Kite Pharma (NASDAQ:KITE), Avalanche Biotechnologies (NASDAQ:AAVL), Oracle Corporation (NYSE:ORCL), Cisco Systems (NASDAQ:CSCO), Dominion Diamond Corporation (NYSE:DDC)
On Friday shares of Kite Pharma, Inc. (NASDAQ:KITE) closed at $58.34. Kite Pharma, Inc. (NASDAQ:KITE) announced that Arie Belldegrun, M.D., FACS, Chairman, President and Chief Executive Officer, will present a company overview at the 2015 Jefferies Immuno-Oncology Summit in Boston. The presentation will take place on Wednesday, April 15, 2015, at 8:10 a.m. EDT. Avalanche…
-
Morning Alert: Avalanche Biotechnologies (NASDAQ:AAVL), Juniper Networks (NYSE:JNPR), First Potomac Realty Trust (NYSE:FPO), XO Group Inc. (NYSE:XOXO)
On Tuesday shares of Avalanche Biotechnologies, Inc. (NASDAQ:AAVL) closed at $38.85. Avalanche Biotechnologies (NASDAQ:AAVL) was downgraded by investment analysts at Vetr from a “buy” rating to a “hold” rating in a note issued to investors on Wednesday. They currently have a $42.50 price target on the stock Juniper Networks, Inc. (NYSE:JNPR) in last trading activity…
-
Big Movers: Spark Therapeutics (NASDAQ:ONCE), Avalanche Biotechnologies (NASDAQ:AAVL), SINA Corporation (NASDAQ:SINA), Arc Logistics Partners LP (NYSE:ARCX), Johnson & Johnson (NYSE:JNJ)
On Thursday shares of Spark Therapeutics, Inc. (NASDAQ:ONCE) closed at $74.17. Spark Therapeutics, Inc. (NASDAQ:ONCE) had its price target upped by JPMorgan Chase & Co. from $74.00 to $82.00 in a research note issued to investors on Thursday. The firm currently has an overweight rating on the stock. Avalanche Biotechnologies, Inc. (NASDAQ:AAVL) in last trading…
-
Top Stories: Avalanche Biotechnologies (NASDAQ:AAVL), AVEO Pharmaceuticals (NASDAQ:AVEO), McKesson Corporation (NYSE:MCK), The Blackstone Group L.P. (NYSE:BX), Electro Scientific Industries (NASDAQ:ESIO)
On Monday shares of Avalanche Biotechnologies, Inc. (NASDAQ:AAVL) closed at $41.75. Avalanche Biotechnologies, Inc. (NASDAQ:AAVL) announced that Thomas W. Chalberg, Jr., Ph.D., Founder and Chief Executive Officer, presented at Barclays Global Healthcare Conference on Tuesday, March 10, 2015 at 2:30 p.m. EDT in Miami, FL. AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) in last trading activity fell -10.00%…
-
Notable Ups And Down: Abbott Laboratories (NYSE:ABT), Avalanche Biotechnologies (NASDAQ:AAVL), Varian Medical Systems (NYSE:VAR), Computer Sciences (NYSE:CSC), Insperity (NYSE:NSP)
On 29 January, Abbott Laboratories (NYSE:ABT) announced Fourth-quarter 2014 worldwide sales from continuing operations of $5.4 billion increased 10.2 percent on an operational basis. Sales increased 5.6 percent on a reported basis, including an unfavorable 4.6 percent effect of foreign exchange. On Monday shares of Abbott Laboratories (NYSE:ABT) closed at $44.52. Company’s sales growth for…